Showing Value in Newborn Screening (NBS): Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria (PKU) and Cystic Fibrosis (CF)
Date:
September 2015
This paper illustrates common problems associated with quantifying the health and economic benefits of population-level screening programs through a review of past economic evaluations of screening for two historically significant conditions, phenylketonuria (PKU) and cystic fibrosis (CF).